Chronic hepatitis C virus (HCV) infection affects around 3.5 million children worldwide, and in Australia, it’s estimated that it affects at least 4 children per million under 15 years old. Children with chronic hepatitis C infection can suffer from reduced quality of life, social stigmatisation, and inadequate access to specialist care. As with adults, the disease can progress to hepatic fibrosis, chronic liver disease, and hepatocellular cancer.
Month: May 2023
More Evidence of DAAs’ Power for Elimination
Author James MorrisonPosted on Categories UncategorisedLeave a comment on More Evidence of DAAs’ Power for Elimination A recent large-scale study confirms that treating chronic hepatitis C patients with direct-acting antivirals (DAA) leads to improved outcomes and better long-term survival.
Continue reading “More Evidence of DAAs’ Power for Elimination”